Sign Up Today and Learn More About Cerebral Stock
Invest in or calculate the value of your shares in Cerebral or other pre-IPO companies through EquityZen's platform.
Cerebral Stock
Mental Health Telemedicine
Cerebral develops an online mental healthcare platform
About Cerebral Stock
Founded
2020
Headquarters
San Francisco, CA, US
Notable Investor
Artis Ventures (AV)
Total Funding
462M
Industries
Cerebral is a mental health telemedicine company. Cerebral offers therapy and medication for patients with mental illnesses such as anxiety or depression. Cerebral claims to offer its platform to individuals, employers, and payers.
Cerebral was founded in 2020 and is headquartered in San Francisco, California. Notable investors include SoftBank Vision Fund, WestCap, and Access Industries.
Cerebral Press Mentions
Stay in the know about the latest news on Cerebral
FTC Fines Mental Health Startup Cerebral $7 Million for Major Privacy Violations
thehackernews • Apr, 18 2024
FTC Bans Cerebral From Harnessing Users' Health Data For Advertising
mediapost • Apr, 18 2024
Cerebral agrees to $7M settlement with FTC, DOJ over user data sharing, cancellation practices
fiercehealthcare • Apr, 18 2024
Telehealth firm Cerebral faces $7m FTC fine over privacy
pharmaphorum • Apr, 18 2024
What Does the FTC’s $7M Fine Against Cerebral Mean for the Industry?
medcitynews • Apr, 18 2024
Investors in Cerebral
Discover investors in Cerebral stock and explore their portfolio companies
Cerebral Management
Leadership team at Cerebral
Chief Executive Officer
Kyle Robertson
Chief Financial Officer
Meg Miller McKenna
Join now and verify your accreditation status to gain access to:
- Cerebral current valuation
- Cerebral stock price
- Available deals in Cerebral and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Cerebral stock?
Accredited investors can buy pre-IPO stock in companies like Cerebral through EquityZen funds. These investments are made available by existing Cerebral shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cerebral stock?
Shareholders can sell their Cerebral stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
